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Erratum to “Blood-brain barrier breakdown,
neuroinflammation, and cognitive decline in older adults”
[Alzheimer’s & Dementia 2018;14:1640-50.]
In the article “Blood-brain barrier breakdown, neuroinflammation, and cognitive decline in older adults,” published in the
December 2018 issue of Alzheimer’s & Dementia, the last sentence within the results and discussion of the abstract should
be omitted to read as follows:
“Mean age was 70 years, mean Mini–Mental State Examination was 27, and BBB impairment was recorded in 13.5%. BBB
breakdown was associated with cognitive decline (P 5 .015). Cerebrospinal fluid intercellular adhesion molecule-1, vascular
endothelial growth factor, interleukin-8, serum amyloid A, macrophage derived chemokine, and gender generated an area under
the curve of 0.95 for BBB impairment, and serum IL-16, VEGF-D, IL-15, and other variables generated an AUC of 0.92 for
BBB impairment.”
“BBB breakdown is associated with more rapid cognitive decline. Inflammatory mechanisms, including cell adhesion, neutro-
phil migration, lipid metabolism, and angiogenesis may be implicated.”
https://doi.org/10.1016/j.jalz.2019.01.001
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ability and dementia: Evidence from 11 cohort studies”
[Alzheimer’s & Dementia 2018;14:707-22.]
In the article “Circulating metabolites and general cognitive ability and dementia: Evidence from 11 cohort studies,” published
in the June 2018 issue of Alzheimer’s & Dementia, the lower bounds of the confidence intervals are noted twice in Table 4. The
corrected table is below.Table 4
Metabolite concentrations associated with dementia and AD
Metabolite
AD Dementia
OR P N cases N total OR P N cases N total
S-HDL-free cholesterol 0.87 [0.81–0.94] 2.3! 1024 1276 22,880 0.85 [0.80–0.91] 4.1! 1027 1881 25,868
M-HDL-phospholipids 0.93 [0.86–1.00] 4.7! 1022 1276 22,884 0.90 [0.85–0.96] 1.8! 1023 1881 25,872
22:6, docosahexaenoic acid 0.89 [0.83–0.96] 1.5! 1023 1334 22,466 0.91 [0.86–0.97] 1.9! 1023 1938 25,417
Glutamine 1.11 [1.04–1.20] 3.1! 1023 1356 25,181 1.08 [1.02–1.15] 1.3! 1022 1990 25,640
M-HDL-cholesterol esters 0.97 [0.89–1.04] 0.38 1276 22,884 0.92 [0.86–0.98] 1.6! 1022 1881 25,872
M-HDL-total cholesterol 0.97 [0.89–1.05] 0.40 1276 22,884 0.92 [0.86–0.98] 1.6! 1022 1881 25,872
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